Cite
MLA Citation
Peter C. Dubsky et al.. “The EndoPredict score predicts response to neoadjuvant chemotherapy and neoendocrine therapy in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients from the ABCSG-34 trial.” European journal of cancer, vol. 134, 2020, pp. 99–106. http://access.bl.uk/ark:/81055/vdc_100104127171.0x00002a